The Mannitol-Asthma-Ciclesonide-Study

Summary

Response of a 4 weeks treatment with daily once 320 µg ciclesonide on airway hyperresponsiveness assessed with mannitol. Hypothesis: Treatment with inhaled ciclesonide reduces airway hyper-responsiveness in 80% of hyper-responsive patients compared to 20% only in the placebo group and the group without airway hyper-responsiveness.

Timeline

Start

2007-06

Primary completion

2008-08

Completion

2008-08

Drugs

Indications